249 related articles for article (PubMed ID: 25337248)
21. Prognostic role of regenerating gene-I in patients with stage-IV head and neck squamous cell carcinoma.
Aboshanif M; Kawasaki Y; Omori Y; Suzuki S; Honda K; Motoyama S; Ishikawa K
Diagn Pathol; 2016 Aug; 11(1):79. PubMed ID: 27539087
[TBL] [Abstract][Full Text] [Related]
22. Programmed cell death-ligand 1 expression in oral squamous cell carcinoma is associated with an inflammatory phenotype.
Satgunaseelan L; Gupta R; Madore J; Chia N; Lum T; Palme CE; Boyer M; Scolyer RA; Clark JR
Pathology; 2016 Oct; 48(6):574-80. PubMed ID: 27590194
[TBL] [Abstract][Full Text] [Related]
23. Distinct expression patterns of Toll-like receptor 7 in tumour cells and fibroblast-like cells in oral squamous cell carcinoma.
Ni YH; Ding L; Zhang DY; Hou YY; Huang X; Hu Q
Histopathology; 2015 Nov; 67(5):730-9. PubMed ID: 25828894
[TBL] [Abstract][Full Text] [Related]
24. PAI-1, CAIX, and VEGFA expressions as prognosis markers in oral squamous cell carcinoma.
Peterle GT; Maia LL; Trivilin LO; de Oliveira MM; Dos Santos JG; Mendes SO; Stur E; Agostini LP; Rocha LA; Moysés RA; Cury PM; Nunes FD; Louro ID; Dos Santos M; da Silva AMÁ
J Oral Pathol Med; 2018 Jul; 47(6):566-574. PubMed ID: 29693741
[TBL] [Abstract][Full Text] [Related]
25. The role of E-cadherin down-regulation in oral cancer: CDH1 gene expression and epigenetic blockage.
Pannone G; Santoro A; Feola A; Bufo P; Papagerakis P; Lo Muzio L; Staibano S; Ionna F; Longo F; Franco R; Aquino G; Contaldo M; De Maria S; Serpico R; De Rosa A; Rubini C; Papagerakis S; Giovane A; Tombolini V; Giordano A; Caraglia M; Di Domenico M
Curr Cancer Drug Targets; 2014; 14(2):115-27. PubMed ID: 24274398
[TBL] [Abstract][Full Text] [Related]
26. Downregulation of DHRS9 is associated with poor prognosis in oral squamous cell carcinoma.
Shimomura H; Sasahira T; Nakashima C; Shimomura-Kurihara M; Kirita T
Pathology; 2018 Oct; 50(6):642-647. PubMed ID: 30149992
[TBL] [Abstract][Full Text] [Related]
27. Pancreatic adenocarcinoma up-regulated factor has oncogenic functions in oral squamous cell carcinoma.
Sasahira T; Kurihara M; Nishiguchi Y; Nakashima C; Kirita T; Kuniyasu H
Histopathology; 2017 Mar; 70(4):539-548. PubMed ID: 27706833
[TBL] [Abstract][Full Text] [Related]
28. Subcellular differential expression of Ep-ICD in oral dysplasia and cancer is associated with disease progression and prognosis.
Somasundaram RT; Kaur J; Leong I; MacMillan C; Witterick IJ; Walfish PG; Ralhan R
BMC Cancer; 2016 Jul; 16():486. PubMed ID: 27421772
[TBL] [Abstract][Full Text] [Related]
29. Increased expression of interleukin-6 predicts poor response to chemoradiotherapy and unfavorable prognosis in oral squamous cell carcinoma.
Jinno T; Kawano S; Maruse Y; Matsubara R; Goto Y; Sakamoto T; Hashiguchi Y; Kaneko N; Tanaka H; Kitamura R; Toyoshima T; Jinno A; Moriyama M; Oobu K; Kiyoshima T; Nakamura S
Oncol Rep; 2015 May; 33(5):2161-8. PubMed ID: 25761055
[TBL] [Abstract][Full Text] [Related]
30. Molecular profiling of tumour budding implicates TGFβ-mediated epithelial-mesenchymal transition as a therapeutic target in oral squamous cell carcinoma.
Jensen DH; Dabelsteen E; Specht L; Fiehn AM; Therkildsen MH; Jønson L; Vikesaa J; Nielsen FC; von Buchwald C
J Pathol; 2015 Aug; 236(4):505-16. PubMed ID: 25925492
[TBL] [Abstract][Full Text] [Related]
31. Urokinase plasminogen activator receptor (uPAR) and plasminogen activator inhibitor-1 (PAI-1) are potential predictive biomarkers in early stage oral squamous cell carcinomas (OSCC).
Magnussen S; Rikardsen OG; Hadler-Olsen E; Uhlin-Hansen L; Steigen SE; Svineng G
PLoS One; 2014; 9(7):e101895. PubMed ID: 24999729
[TBL] [Abstract][Full Text] [Related]
32. The prognosis outcome of oral squamous cell carcinoma using HIF-2α.
Lim E; Kuo CC; Tu HF; Yang CC
J Chin Med Assoc; 2017 Oct; 80(10):651-656. PubMed ID: 28690120
[TBL] [Abstract][Full Text] [Related]
33. [The prognostic importance of urinase type plasminogen activators (uPA) and plasminogen activator inhibitors (PAI-1) in the primary resection of oral squamous cell carcinoma].
Hundsdorfer B; Zeilhofer HF; Bock KP; Dettmar P; Schmitt M; Horch HH
Mund Kiefer Gesichtschir; 2004 May; 8(3):173-9. PubMed ID: 15138855
[TBL] [Abstract][Full Text] [Related]
34. Comprehensive study on the prognostic role of osteopontin expression in oral squamous cell carcinoma.
Chien CY; Su CY; Chuang HC; Fang FM; Huang HY; Chen CH; Chen CM; Huang CC
Oral Oncol; 2009 Sep; 45(9):798-802. PubMed ID: 19213594
[TBL] [Abstract][Full Text] [Related]
35. Expression of caveolin-1 is correlated with disease stage and survival in lung adenocarcinomas.
Zhan P; Shen XK; Qian Q; Wang Q; Zhu JP; Zhang Y; Xie HY; Xu CH; Hao KK; Hu W; Xia N; Lu GJ; Yu LK
Oncol Rep; 2012 Apr; 27(4):1072-8. PubMed ID: 22200856
[TBL] [Abstract][Full Text] [Related]
36. Expression of plasminogen activator inhibitor-1, urokinase receptor and laminin gamma-2 chain is an early coordinated event in incipient oral squamous cell carcinoma.
Lindberg P; Larsson A; Nielsen BS
Int J Cancer; 2006 Jun; 118(12):2948-56. PubMed ID: 16395714
[TBL] [Abstract][Full Text] [Related]
37. Clinical implications of heat shock protein 70 in oral carcinogenesis and prediction of progression and recurrence in oral squamous cell carcinoma patients: a retrospective clinicopathological study.
Elhendawy HA
Eur J Med Res; 2023 Oct; 28(1):464. PubMed ID: 37884988
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of KLF17 Predicts a Favorable Prognosis in Patients with Oral Squamous Cell Carcinoma: A Retrospective Study.
Lee YJ; Chan L; Yeh CM; Lee CH; Sung WW
Medicina (Kaunas); 2020 Jan; 56(2):. PubMed ID: 32019121
[TBL] [Abstract][Full Text] [Related]
39. Predictive markers for delayed lymph node metastases and survival in early-stage oral squamous cell carcinoma.
Luksic I; Suton P
Head Neck; 2017 Apr; 39(4):694-701. PubMed ID: 28006084
[TBL] [Abstract][Full Text] [Related]
40. Lymphatic Vascular Density, the Expression of Podoplanin and Tumor Budding in Oral Squamous Cell Carcinoma.
de Assis EM; Rodrigues M; Vieira JC; Pascoaloti MIM; Junior HM; Souto GR; Souza PEA; Horta MCR
Head Neck Pathol; 2023 Jun; 17(2):371-382. PubMed ID: 36480090
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
